ArticleEuropean journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery2025
Disparities in heart transplant survival and graft rejection outcomes persist in the modern era: a call to race towards a more equitable future.
Article in European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- A systematic review of the relationship between race and health-related quality of life outcomes in patients with advanced heart failure who undergo heart transplantation or mechanical circulatory support.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2026Pooled it
- High-volume centers achieve superior outcomes in left ventricular assist device explant-heart transplantation.JTCVS open · 2026Article
- Regulatory T cells in cardiac allograft vasculopathy: from mechanistic insights to clinical tolerance.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesRacial and ethnic disparities remain an ongoing challenge in healthcare. Such inequities have been reported in heart transplantation (HTx); however, there is limited data within the modern era. Additionally, there is scarce information on outcomes besides death, such as graft rejection. Therefore, our investigation aims to add further data on contemporary racial and ethnic disparities on post-transplant outcomes.
methodsAdult isolated HTx recipients who were transplanted between 1/2000 and 9/2023 were analysed using the United Network for Organ Sharing (UNOS) database. Inclusion criteria included 'White', 'Black', 'Hispanic' and 'Asian' recipients. Two primary outcomes of interest were analysed: mortality and cardiac allograft vasculopathy (CAV). Survival was assessed using a cause-specific model, whereas CAV analysis utilized a competing-risk approach. Subgroup survival analysis was conducted for patients listed in the years prior to (11/2013-10/2018) and after (10/2018-9/2023) the 2018 heart allocation policy (HAP) changes.
resultsA total of 50 243 patients were included in our analysis. Black recipients were the only group found to have an increased overall (hazard ratio [HR] = 1.30, P < 0.001) and post-HAP (HR = 1.36, P < 0.001) mortality risk. Asian (HR = 1.19, P= 0.001) and Hispanic (HR = 1.15, P < 0.001) recipients had elevated risks of CAV, whereas Black patients had similar risk (HR = 1.00, P = 0.864) as White recipients.
conclusionsOur investigation suggests that disparities continue to exist for minority groups after HTx. Notably, the 2018 allocation changes may have introduced or exacerbated such inequities for Black recipients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.